PJP (n = 78) | CMV-P (n = 34) | P-value | |
---|---|---|---|
Age (years), median (IQR) | 33 (29, 45) | 38 (29, 48) | 0.12 |
Male, n (%) | 75 (96.15) | 33 (97.06) | 0.81 |
Weight (kg), mean(SD) | 64.05 (11.20) | 62.82 (9.99) | 0.58 |
Transmission route, n (%) | 0.41 | ||
Homosexual | 25 (32.05) | 12 (35.29) | |
Heterosexual | 9 (11.54) | 1 (2.94) | |
Intravenous drug | 1 (1.28) | 0 | |
Blood transfusion | 3 (3.85) | 1 (2.94) | |
Unknown | 40 (51.28) | 20 (58.82) | |
Leukocyte count (× 109/L), median (IQR) | 5.50 (3.64, 8.57) | 4.52 (3.20, 6.85) | 0.22 |
Neutrophil percentage(%), median (IQR) | 79.39 (61.08, 86.42) | 68.15 (56.18, 79.50) | 0.01 |
Lymphocyte percentage (%), median (IQR) | 11.91 (8.48, 19.54) | 18.20 (12.10, 27.24) | 0.02 |
CRP (mg/L), median (IQR) | 12.65 (3.40, 36.23) | 13.30 (2.70, 35.23) | 0.75 |
HIV viral load log10 (copy/ml), median (IQR) | 5.50 (5.17, 5.93) | 5.19 (4.51, 5.67) | 0.02 |
CD4 T cell count (cells/μl), median (IQR) | 22 (9, 47.75) | 22.50 (13, 77) | 0.28 |
CD8 T cell count (cells/μl), median (IQR) | 458 (329.75, 679) | 485.50 (323.75, 779.50) | 0.54 |
CD4/CD8 ratio (%), median (IQR) | 0.05 (0.02, 0.10) | 0.06 (0.02, 0.16) | 0.48 |